Watchlist

Watchlist
Applied DNA Sciences Inc (APDN)
Applied DNA Sciences Inc (APDN)
Applied DNA Sciences' (APDN) CEO James Hayward on Q2 2018 Results - Earnings Call Transcript
Applied DNA Sciences Inc. (APDN) Q2 2018 Earnings Conference Call May 3, 2018 16:30 ET Executives Clay Shorrock - General Counsel James Hayward - Chairman and Chief Executive Officer Beth Jantzen - Chief Financial Officer Judith Murrah - Chief Information Officer Analysts …
Applied DNA Sciences, Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Applied DNA Sciences, Inc. in conjunction with their 2018 Q2 earnings Read more …
Applied DNA Sciences beats by $0.05, beats on revenue
Applied DNA Sciences (NASDAQ: APDN ): Q2 EPS of -$0.07 beats by $0.05 . More news on: Applied DNA Sciences, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more …
Applied DNA Reports Fiscal Second Quarter 2018 Financial Results
-Submits Drug Master File to FDA for Administrative Review- -Signs $2.5 Million in Non-Textile Contracts- -Company to Hold Conference Call and Webcast Today, Thursday, May 3, 2018 at 4:30 PM ET- Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "C…
Applied DNA Sciences Pens Deal with WestPoint Home for CertainT Program
The deal will verify recycled PET and PET for WestPoint Homes hospitality bed and bath textiles Applied DNA Sciences, Inc. (NASDAQ: APDN, Applied DNA, the Company), has signed a multi-year license agreement (the Agreement) with…
Applied DNA Successfully Completes Leather Tagging from Farm to Finished Products
Plans Being Implemented for Follow-on Scale up, and Sponsored Projects Applied DNA Sciences, Inc. , (NASDAQ:APDN) (Applied DNA or the Company,) announces the successful completion of its 1-year (approx.) consortium research project with BLC Leather Tec…
Applied DNA Schedules Fiscal 2018 Second Quarter Financial Results Conference Call for Thursday, May 3, 2018 at 4:30 PM ET
Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2018 second quarter ended March 31, 2018 after market close on Thursday, May 3, 2018. In conjunction with the release, the Company has scheduled a conference call at 4:30 p.m. Ea…
Applied DNA to Debut Security Print Platform Solution Featuring Videojet 1860M CIJ Printer at INTERPHEX 2018
Supply Chain Management Tool Provides Proactive Global Tag-Test-Track Capability with Both Black and Invisible Inks Qualified Applied DNA Sciences, Inc . (NASDAQ: APDN) (Applied DNA or the Company) will debut its security print platform solution featur…
Your Daily Pharma Scoop: Conatus Setback, Applied DNA Signs Agreement, Evolus Announces Results From Late-Stage Study
A nalysis focus: Conatus Conatus (NASDAQ: CNAT ) shares tumbled after the company announced top-line results from a phase 2b POLT-HCV-SVR clinical study. The phase 2b study was evaluating CNATs lead product candidate emricasan, a first-in-class pan-caspase protease inhibitor …
Applied DNA inks deal with Colorcon which grants use of molecular tags in the pharmaceutical and nutraceutical markets
Applied DNA Sciences(NASDAQ: APDN ) signs a License and Cooperation Agreement and a related Supply Agreement, effective March 31, with Colorcon, Inc. More news on: Applied DNA Sciences, Inc., Tech stocks news, Stocks on the move, Read more …
Applied DNA Sciences Inc (APDN)